Refining Clinical Risk Stratification for Estimating the Risk of Ischemic Stroke in Non-Atrial Fibrillation Patients with a Novel Risk Stratification Tool, CHA₂DS₂-Vasc + Score

医学 心房颤动 冲程(发动机) 血脂异常 内科学 心脏病学 心力衰竭 糖尿病 弗雷明翰风险评分 回顾性队列研究 疾病 机械工程 工程类 内分泌学
作者
Abinesh Sekar,Maya Gogtay,Harinivaas Shanmugavel Geetha,Ankushi Sanghvi,Yuvaraj Singh,P.L. Balani,Deep Shah,Sam George
出处
期刊:Blood [Elsevier BV]
卷期号:140 (Supplement 1): 13031-13032
标识
DOI:10.1182/blood-2022-167941
摘要

Background and Aims: The CHA₂DS₂-VASc score is a well-established tool that predicts the risk of cerebrovascular accident (CVA) in patients with atrial fibrillation. It has also been validated to predict long-term stroke outcomes and cardiovascular disease burden in patients with and without atrial fibrillation as it encompasses most risk factors for ischemic stroke. However, it does not incorporate two important risk factors for ischemic stroke which are dyslipidemia and tobacco use. It has been well established in several studies that these risk factors confer an increased risk for stroke. We combined these risk factors with the traditional CHA₂DS₂-VASc scoring to create a novel CHA₂DS₂-VASc + score. We aimed to assess the ability of CHA₂DS₂-VASc+ scoring to screen ischemic CVA in patients without atrial fibrillation. Methods: This retrospective cohort study was approved by the institutional review board (IRB). The study included patients with CVA symptoms who had magnetic resonance imaging (MRI) of the brain and excluded those with atrial fibrillation, intracranial hemorrhage, history of migraine, seizure disorder, and brain tumors. We collected data on demographics, clinical presentation (facial droop, side of weakness, presence of aphasia), home medications, laboratory tests, and imaging results. For calculating the CHA₂DS₂-VASc+ score, we used the traditional parameters of the original score; congestive heart failure (CHF), hypertension, age, diabetes mellitus (DM), prior CVA or thromboembolism, hypertension (HTN), vascular disease, and sex. In addition to this, we assigned one point each, for dyslipidemia and tobacco use. The dyslipidemia criterion was a total cholesterol >240 mg/dl, triglycerides >200 mg/dl, LDL >160 mg/dl, or HDL <40 mg/dl. The criteria for tobacco use was that of a current or former smoker with more than ≥ 15 pack years history. Mann-Whitney U test was used for continuous variables and the chi-square test was used for categorical variables. Results: Of the total 500 patients screened, 222 patients met the inclusion criteria. There were 138 patients with MRI evidence of infarct vs 84 without evidence of infarct. Demographic data including age and sex were distributed equally between the two groups. There was no significant difference in the risk factors between the two groups which included HTN, CHF, and DM, NIHSS score, HLD, tobacco use, prior statins, antiplatelet and anticoagulant use. The CHADVASc score was equally distributed between the two groups as well. A total of 146 patients were found to have a CHA₂DS₂-VASc+ score of ≥ 4 and when this was used as a cut-off, there was a statistically significant difference seen as 71% of patients with imaging evidence of a stroke had a score of ≥ 4 vs 57.1% of patients without imaging evidence of stroke [ OR=1.838, (95 % CI: 1.042-3.241), p- 0.035] (as shown in table 1). We also calculated the CHA₂DS₂-VASc score and among patients with a score ≥ 4, only 53.6% had imaging evidence of infarct vs. 47.6% in the other group (p-0.385). The ROC curve analysis for the CHA₂DS₂-VASc+ score showed an Area of 0.539 (as in Fig 1), sensitivity of 70.3%, and specificity of 42.8%. The positive predictive value (PPV) was 66.7%, and the negative predictive value (NPV) was 46.9%. Conclusion: Our results indicate that CHA₂DS₂-VASc+ scoring may be a useful predictor in estimating the risk of ischemic CVA in non-atrial fibrillation patients. Smoking and dyslipidemia are well studied risk factors for CVA and including these factors in addition to the original CHA₂DS₂-VASc scoring may help increase its sensitivity. Considering the findings of our single-center study, we would recommend a large-scale prospective trial to validate the CHA₂DS₂-VASc+ score. Further studies with head-to-head comparison of CHA₂DS₂-VASc+ and CHA₂DS₂-VASc in assessing their sensitivity for predicting ischemic CVA could potentially enhance our existing tools. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
韭黄完成签到,获得积分20
1秒前
jeffrey完成签到,获得积分10
1秒前
Rondab应助机灵枕头采纳,获得10
7秒前
佳无夜完成签到,获得积分10
12秒前
摆哥完成签到,获得积分10
16秒前
66完成签到,获得积分10
21秒前
zlqq完成签到 ,获得积分10
21秒前
Hardskills发布了新的文献求助10
24秒前
25秒前
之_ZH完成签到 ,获得积分10
33秒前
gds2021完成签到 ,获得积分10
35秒前
你好呀嘻嘻完成签到 ,获得积分10
35秒前
梅特卡夫完成签到,获得积分10
37秒前
熊雅完成签到,获得积分10
38秒前
40秒前
睡到自然醒完成签到 ,获得积分10
41秒前
cis2014完成签到,获得积分10
43秒前
独特的大有完成签到 ,获得积分10
43秒前
量子星尘发布了新的文献求助10
44秒前
46秒前
xingyi完成签到,获得积分10
48秒前
49秒前
舒心的秋荷完成签到 ,获得积分10
52秒前
zz123发布了新的文献求助10
53秒前
liaomr完成签到 ,获得积分10
53秒前
粗犷的灵松完成签到,获得积分10
54秒前
吃小孩的妖怪完成签到 ,获得积分10
54秒前
ncuwzq完成签到,获得积分10
56秒前
yshj完成签到 ,获得积分10
57秒前
59秒前
净禅完成签到 ,获得积分10
1分钟前
1分钟前
迷人的寒风完成签到,获得积分10
1分钟前
1分钟前
water应助科研通管家采纳,获得10
1分钟前
Lucas应助HHHAN采纳,获得10
1分钟前
无情修杰完成签到 ,获得积分10
1分钟前
小柒完成签到 ,获得积分10
1分钟前
聪慧芷巧发布了新的文献求助10
1分钟前
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022